Brokerages Set Waystar Holding Corp. (NASDAQ:WAY) PT at $35.62

Shares of Waystar Holding Corp. (NASDAQ:WAY) have been assigned a consensus recommendation of “Buy” from the twenty-three analysts that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, seventeen have assigned a buy recommendation and three have assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $35.6190.

A number of research firms recently issued reports on WAY. UBS Group decreased their price objective on Waystar from $41.00 to $37.00 and set a “buy” rating on the stock in a research note on Thursday, April 30th. Truist Financial decreased their price objective on Waystar from $51.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, February 18th. Barclays decreased their price objective on Waystar from $36.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 20th. The Goldman Sachs Group decreased their price objective on Waystar from $44.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, February 18th. Finally, Canaccord Genuity Group decreased their price objective on Waystar from $54.00 to $30.00 and set a “buy” rating on the stock in a research note on Wednesday, February 18th.

Institutional Trading of Waystar

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in Waystar by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 12,330,872 shares of the company’s stock worth $403,836,000 after buying an additional 41,062 shares in the last quarter. Advent International L.P. purchased a new position in Waystar during the fourth quarter worth about $362,212,000. William Blair Investment Management LLC grew its position in Waystar by 0.4% during the fourth quarter. William Blair Investment Management LLC now owns 5,282,220 shares of the company’s stock worth $172,993,000 after buying an additional 19,033 shares in the last quarter. State Street Corp grew its position in Waystar by 4.0% during the fourth quarter. State Street Corp now owns 4,134,052 shares of the company’s stock worth $135,390,000 after buying an additional 159,183 shares in the last quarter. Finally, Alliancebernstein L.P. grew its position in Waystar by 4.5% during the third quarter. Alliancebernstein L.P. now owns 3,415,442 shares of the company’s stock worth $129,514,000 after buying an additional 146,510 shares in the last quarter.

Waystar Stock Performance

Shares of WAY opened at $18.98 on Tuesday. The firm has a market cap of $3.64 billion, a PE ratio of 28.33, a PEG ratio of 0.79 and a beta of 0.11. The stock’s fifty day moving average price is $21.87 and its two-hundred day moving average price is $26.61. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76. Waystar has a 1 year low of $17.89 and a 1 year high of $41.49.

Waystar (NASDAQ:WAY) last issued its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.03. The firm had revenue of $313.87 million for the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The business’s revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 earnings per share. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, equities research analysts forecast that Waystar will post 1.46 EPS for the current year.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.